Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PHOX2B PC CAR-T cells |
| Synonyms | |
| Therapy Description |
PHOX2B PC CAR-T cells are autologous T-lymphocytes expressing a peptide-centric chimeric antigen receptor (CAR) targeting an unmutated PHOX2B peptide, which potentially induces IFN-gamma release and tumor cell killing (PMID: 37938771). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PHOX2B PC CAR-T cells | PHOX2B PC CAR-T cells are autologous T-lymphocytes expressing a peptide-centric chimeric antigen receptor (CAR) targeting an unmutated PHOX2B peptide, which potentially induces IFN-gamma release and tumor cell killing (PMID: 37938771). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07007117 | Phase I | PHOX2B PC CAR-T cells | PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma (PHOX2B) | Recruiting | USA | 0 |